Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanny Al-Samkari

Showing results (51-60 of 201) with videos related to

Pageof 21
Sort By:
Expert Review of Hematology|April 30, 2021
Clinical challenges and promising therapies for chemotherapy-induced thrombocytopeniaHanny Al-Samkari, Gerald A Soff
American Journal of Hematology|June 10, 2018
Shifting Landscape of Hemophilia Therapy: Implications for Current Clinical Laboratory Coagulation AssaysHanny Al-Samkari, Stacy E Croteau
British Journal of Clinical Pharmacology|July 23, 2018
An alternative intermittent eltrombopag dosing protocol for the treatment of chronic immune thrombocytopeniaHanny Al-Samkari, David J Kuter
Journal of Oncology Practice|November 11, 2017
Anticoagulation and Enzalutamide: Caution Over ConvenienceHanny Al-Samkari, Jean M Connors
British Journal of Haematology|October 7, 2021
TPO versus TPO: the good, the bad, and the to be determinedEun-Ju Lee, Hanny Al-Samkari
American Journal of Hematology|September 7, 2018
Thrombopoietin level predicts response to treatment with eltrombopag and romiplostim in immune thrombocytopeniaHanny Al-Samkari, David J Kuter
British Journal of Haematology|July 7, 2018
Relative potency of the thrombopoietin receptor agonists eltrombopag, avatrombopag and romiplostim in a patient with chronic immune thrombocytopeniaHanny Al-Samkari, David J Kuter
Expert Review of Hematology|April 11, 2023
Emerging data on thrombopoietin receptor agonists for management of chemotherapy-induced thrombocytopeniaAndrew B Song, Hanny Al-Samkari
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 8, 2020
Beliefs, opinions and impact of emicizumab in haemophilia A patients: A National US Survey StudyHanny Al-Samkari, Stacy E Croteau
Expert Review of Clinical Immunology|July 6, 2022
An updated evaluation of avatrombopag for the treatment of chronic immune thrombocytopeniaAndrew B Song, Hanny Al-Samkari
Pageof 21

Showing results (51-60 of 201) with videos related to

Sort By:
Pageof 21
Expert Review of Hematology|April 30, 2021
Clinical challenges and promising therapies for chemotherapy-induced thrombocytopeniaHanny Al-Samkari, Gerald A Soff
American Journal of Hematology|June 10, 2018
Shifting Landscape of Hemophilia Therapy: Implications for Current Clinical Laboratory Coagulation AssaysHanny Al-Samkari, Stacy E Croteau
British Journal of Clinical Pharmacology|July 23, 2018
An alternative intermittent eltrombopag dosing protocol for the treatment of chronic immune thrombocytopeniaHanny Al-Samkari, David J Kuter
Journal of Oncology Practice|November 11, 2017
Anticoagulation and Enzalutamide: Caution Over ConvenienceHanny Al-Samkari, Jean M Connors
British Journal of Haematology|October 7, 2021
TPO versus TPO: the good, the bad, and the to be determinedEun-Ju Lee, Hanny Al-Samkari
American Journal of Hematology|September 7, 2018
Thrombopoietin level predicts response to treatment with eltrombopag and romiplostim in immune thrombocytopeniaHanny Al-Samkari, David J Kuter
British Journal of Haematology|July 7, 2018
Relative potency of the thrombopoietin receptor agonists eltrombopag, avatrombopag and romiplostim in a patient with chronic immune thrombocytopeniaHanny Al-Samkari, David J Kuter
Expert Review of Hematology|April 11, 2023
Emerging data on thrombopoietin receptor agonists for management of chemotherapy-induced thrombocytopeniaAndrew B Song, Hanny Al-Samkari
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 8, 2020
Beliefs, opinions and impact of emicizumab in haemophilia A patients: A National US Survey StudyHanny Al-Samkari, Stacy E Croteau
Expert Review of Clinical Immunology|July 6, 2022
An updated evaluation of avatrombopag for the treatment of chronic immune thrombocytopeniaAndrew B Song, Hanny Al-Samkari
Pageof 21